Jane Street’s Pulse Biosciences PLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-34,151
Closed -$604K 12092
2025
Q3
$604K Buy
34,151
+9,900
+41% +$157K ﹤0.01% 7445
2025
Q2
$366K Buy
24,251
+4,146
+21% +$68.8K ﹤0.01% 7491
2025
Q1
$323K Buy
+20,105
New +$375K ﹤0.01% 7676
2024
Q4
Sell
-13,281
Closed -$233K 10285
2024
Q3
$233K Sell
13,281
-15,425
-54% -$263K ﹤0.01% 8426
2024
Q2
$321K Buy
28,706
+974
+4% +$9.18K ﹤0.01% 7700
2024
Q1
$242K Sell
27,732
-5,846
-17% -$53.7K ﹤0.01% 7895
2023
Q4
$411K Buy
+33,578
New +$233K ﹤0.01% 7109
2017
Q2
Sell
-11,908
Closed -$243K 4741
2017
Q1
$243K Buy
+11,908
New +$162K ﹤0.01% 3665

Other funds holding PLSE

Jane Street's PLSE Position: Q4 2025 in Review

Jane Street sold out of Pulse Biosciences (PLSE) in Q4 2025, closing a stake of 34,151 shares — an estimated $604K sold.

Jane Street first reported a position in PLSE in Q1 2017 and held it in 8 quarters. The position peaked at $604K in Q3 2025. 82 funds tracked by Wall St. Rank hold PLSE as of Q4 2025.

  • Jane Street reported no remaining Pulse Biosciences position as of Q4 2025 after selling out during the quarter.
  • Jane Street sold 34,151 Pulse Biosciences shares in Q4 2025, an estimated $604K.
  • Jane Street first reported a position in Pulse Biosciences in Q1 2017 and held it in 8 quarters.
  • Jane Street's Pulse Biosciences position peaked at $604K in Q3 2025.
  • 82 funds tracked by Wall St. Rank held Pulse Biosciences as of Q4 2025.

Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.